Ethics and transparency

Cooperation with patient organizations

The patient comes first

For Bayer, one of the world's leading specialty pharmaceutical companies, patients' health always comes first. Exchanging ideas and information with patient organizations on the basis of mutual trust is an important component of our work.

Such cooperation helps us to understand the needs of patients as they come to terms with their illness. This enables us to gear our research and development to these needs and to continue working on improved, new drugs and therapies.

Bayer cooperates with patient organizations in all kinds of therapeutic areas. We attach great importance to transparency in this context and protect the independence of our cooperation partners.

Our principles

Cooperation between Bayer and patient organizations is based on the following principles.

  1. In order to provide patients with quality medical healthcare, a partnership with a patient organization pursues a specific objective concentrating on one or more of the following areas:
    • raising awareness for certain diseases by improving diagnostic possibilities and preventive measures, knowing the patients' prospects and needs,
    • understanding diseases and making sure that patients receive the best medical treatment available,
    • improving the information provided to the patients,
    • supporting medical innovations.
  2. Bayer and the patient organizations comply with international and national laws and regulations.
  3. Cooperation with a patient organization should neither influence decisions on a therapy nor promote or support specific therapies.
  4. Bayer respects the neutrality and independence of patient organizations. Cooperation is based on a partnership between equals in which transparency and clarity are fundamental principles. This is why we also provide information on the extent and nature of support.

Overview of cooperation with patient organizations in Europe in 2015

The following is a list of patient organizations with which Bayer and its affiliated companies in Europe cooperated in 2015.

Patient Organizations Country of Organization's Office Nature and Purpose of Support Value in Euro Travel costs
Cittadinanzattiva Italy Support of the organization's multi-sponsored "9th European Patient's Rights Day" in Brussels, May 12, 2015 10,000 no
Deutsche Diabetes-Hilfe - Menschen mit Diabetes (DDH-M) Germany Presentation for Bayer at a press event on September 17, 2015 in Nice, France no 242,98
Deutscher Blinden- und Sehbehindertenverband e. V. Germany Presentation for Bayer at a press event on September 17, 2015 in Nice, France no 561,02
Deutscher Blinden- und Sehbehindertenverband e. V. Germany Presentation for Bayer at a press event on September 17, 2015 in Nice, France no 222,58
ELPA (European Liver Patients Association) Belgium Support of PO to send one representative to the Bayer advocacy round table, Chicago (USA) June 1, 2015 with Bayer senior management and international patient advocates to exchange on how to best address challenges in patient access to innovative care, best practice on working collaboratively around patient needs and communication methods no 5978,72
ELPA (European Liver Patients Association) Belgium Support of PO to send one representative to the Bayer Advisory Board Meeting "Patient Clinical Trial Education and Information", Whippany (USA) April 4, 2015, to provide the patient advocate perspective on patient's experiences with clinical trial information no 4626,74
EuropaColon UK Support core and project activities of PO in 2015, including policy round tables, patient unmet objective need analysis and patient education activities 50,000 no
EuropaUomo Belgium Support of PO to send one representative to the Bayer Advisory Board Meeting "Patient Clinical Trial Education and Information", Whippany (USA) April 9, 2015, to provide the patient advocate perspective on patient's experiences with clinical trial information no 5101,43
European Alliance for Personalised Medicine Belgium Annual Partnership for continued collaboration / "STEPs in the Right Direction" initiative on an EU policy level 40,000 no
European Haemophilia Consortium (EHC) Belgium Sponsorship of Annual Conference of EHC (2015) 25,500 no
European Haemophilia Consortium (EHC) Belgium Membership of the EHC's Corporate Giving Program and EHC's Round Tables 40,000 no
European Multiple Sclerosis Platform (EMSP) Belgium Financial support of PO’s key projects: EMSP's Annual Spring Conference, MS Nurse, PRO online training, European awareness raising campaign "Under Pressure" and European MS Register EUReMS. 50,000 no
European Society of Gynaecological Oncology (ESGO) Switzerland Support core and project activities of PO regarding the ENGAGe initiative of ESGO in 2015, including patient seminars, development and dissemination of educational resources 30,000 no
EURORDIS France Support PO regarding their activities in building initiatives to break the isolation of rare disease patients and their families in Europe including PO’s fundraising dinner in 2015 and communication activities associated with this event 35,000 no
Federazione A.L.I.Ce. Italia Onlus Italy Support of the organization's activities regarding education and awareness raising on the subject of stroke and atrial fibrillation 80,238 no
FEND (Foundation of European Nurses in Diabetes) UK Support of the 20th annual FEND conference, September 11-12, 2015 in Stockholm (Sweden) 15,000 no
Fundacja Udaru Mózgu Poland Support of awareness-related activities regarding the Atrial Fibrillation Patient Charta as part of the organization's campaign "Prevent Stroke" 18,400 no
German Working Group on Castration-Resistant Prostate Cancer e.V. Germany Support of Development of a patient White Book on bone health and MetastaticCastration-resistant Prostate Cancer (mCRPC) 22,000 no
IAPB Trading Ltd. (London School of Hygiene & Tropical Medicine) UK Support of the World Sight Day and Council of Members Meeting 2015 35,511 no
International Agency for the Prevention of Blindness (IAPB) UK Support in advocating the implementation of the Universal Eye Health and the Global Action Plan within member countries and in managing the learning and development program for VISION 2020 88,779 no
International Diabetes Federation Belgium Support of PO and continued engagement Diabetic Retinopathy (DR) Barometer activities and secondary data analysis and publication 72,145 no
International Kidney Cancer Coalition (IKCC) Germany Support of the 5th annual conference, Morristown (USA), April 16-18, 2015 42,000 no
International Planned Parenthood Federation European Network (IPPFEN) Belgium Support of PO regarding launch, communication and policy activities of the publication of the 2015 edition of the Barometer on "Women's Access to Modern Contraceptive-Choice-in the EU" 85,000 no
Myeloma UK UK Support of PO to send one representative to the Bayer advocacy round table, Chicago (USA) June 1, 2015 with Bayer senior management and international patient advocates to exchange on how to best address challenges in patient access to innovative care, best practice on working collaboratively around patient needs and communication methods no yes
PHA Europe Austria Support for their advocacy work, their annual general meeting and their fellowship program in 2015 120,000 no
PHA Europe Austria Support of patient organisation's campaign to raise a broader awareness around World Pulmonary Hypertension Day (WPHD (incl. support “IronMan 2015” in Frankfurt 25,000 no
PHA Europe Austria Support of PO regarding EU Policy Campaigns related to Pulmonary Hypertension 50,000 no
PHA Europe Austria Presentation at the 6th International Nurse Forum, July 2015 no 489,27
PHA Latvia Latvia Presentation at the 6th International Nurse Forum, July 2015 560 34,71
PHA Latvia Latvia Presentation at the 6th International Nurse Forum, July 2015 560 13,45
Sarcoma Patients EuroNet Association (SPAEN) Germany Support of PO regarding their core and project activities in 2015, including the SPAEN Annual Conference, and objective patient education activities 22,000 no
Stroke Alliance for Europe (SAFE) UK Sponsorship of the SAFE Working Conference and General Assembly 2015 75,460 no
Union for International Cancer Control (UICC) Switzerland Support of PO in a partnership agreement for the years 2015, with support of UICC advocacy program, incl. initiatives such as World Cancer Day, World Cancer Congress, Leaders' Summit and various objective workshop meetings 22,196 no
Country More Information
Austria Country website

Baltic States Reports can be received from UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
Belgium/Luxemburg (French) Country website
Belgium/Luxemburg (Dutch) Country website
Bulgaria Country website
Croatia Country website
Czech Republic Country website
Denmark Country website
Estonia Reports can be received from UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania)
Alina Tikuišiene MD
Zirmunu str. 68A
LT-09124 Vilnius/Lithunia
Finland Country website
France Country website
Germany Country website
Greece Country website
Hungary Country website
Iceland Reports can be received from Bayer AB- Bayer Scandinavia
Iina Wargh
Gustav III:s Boulevard 56
169 26 Solna
Ireland Country website
Italy Country website
Latvia Country website
Lithuania Country website
Netherlands Country website
Norway Country website
Poland Country website
Portugal Country website
Romania Reports can be received from SC Bayer SRL
Bayer Pharmaceuticals Division
Sos. Pipera nr. 42., Sector 2
NUSCO Tower fl. 1,16,17
020112, Bucharest
Romania
Serbia Reports can be received from Bayer Pharma d.o.o. 
Jelena Tokanovic
Omladinskih brigada 88b
Belgrade
Slovenia Reports can be received from Bayer d.o.o. 
Lucija Zlodi Gosnik
Bravnicarjeva 13
1000 Ljubljana
Slovakia Country website
Spain Country website
Sweden Country website
Switzerland Country website
Turkey Country website
UK Country website
Ukraine Country website

Donations in Germany

Social responsibility is at the core of Bayer’s identity. For us, donations are an effective way of expressing this responsibility and engaging in social action. Bayer provides financial resources and donations of drugs and cash to support projects worldwide dealing with health and scientific research.

We have published a list of projects that Bayer and its cooperating companies supported with donations in 2015. We published this list in compliance with the code of conduct of the association Voluntary Self-Regulation of the Pharmaceutical Industry ("Freiwillige Selbstkontrolle für die Arzneimittelindustrie"). Since the legally required disclosures are specific German requirements, the list of projects is only available in German: http://www.gesundheit.bayer.de/de/engagement/patientenorganisationen/projekte/index.php

Contact us

Eva Christine Bretschneider
Eva Christine Bretschneider

R&D Media and Partner Relations